LABORATORY RESEARCH Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells Scientists used the LNCaP prostate cancer cell line, which harbors the androgen receptor mutation most commonly detected in castrate-resistant tumors, analysing alterations in the proteome and comparing these to the effect of these therapeutics upon androgen receptor activity and cell proliferation. [Mol Cell Proteomics] Abstract | Full Article Autophagy Modulates the Effects of Bis-Anthracycline WP631 on p53-Deficient Prostate Cancer Cells Treatment of p53-deficient PC-3 human prostate carcinoma cells with nanomolar concentrations of bis-anthracycline WP631 induced changes in gene expression, which resulted in G2/M cell cycle arrest, autophagy and cell death. [J Cell Mol Med] Full Article IL-17 and Insulin/IGF1 Enhance Adhesion of Prostate Cancer Cells to Vascular Endothelial Cells through CD44-VCAM-1 Interaction Human umbilical vein endothelial cells (HUVECs) and human prostate cancer cell lines were analyzed for expression of vascular cell adhesion molecule 1 (VCAM-1), integrins, and cluster of differentiation 44 (CD44) using flow cytometry and Western blot analysis. The effects of interleukin-17 (IL-17), insulin, and insulin-like growth factor 1 (IGF1) on VCAM-1 expression and adhesion of prostate cancer cells to HUVECs were examined. [Prostate] Abstract Expression and Functional Role of Orphan Receptor GPR158 in Prostate Cancer Growth and Progression Researchers provide evidence of a role for the newly characterized glutamate family member GPR158 in prostate cancer (PCa) growth and progression. They found that GPR158 promotes PCa cell proliferation independent of androgen receptor functionality and that this requires its localization in the nucleus of the cell. [PLoS One] Full Article p,p′-Dichlorodiphenyltrichloroethane (p,p′-DDT) and p,p′-Dichlorodiphenyldichloroethylene (p,p′-DDE) Repress Prostate Specific Antigen Levels in Human Prostate Cancer Cell Lines Scientists determined whether environmentally relevant concentrations of p,p′-DDT and p,p′-DDE negatively impact androgen receptor (AR)-regulated expression of prostate-specific antigen, and other AR target genes in human LNCaP and VCaP prostate cancer cells. [Chem Biol Interact] Abstract CC-Chemokine Receptor 7 Is Overexpressed and Correlates with Growth and Metastasis in Prostate Cancer Scientists investigated the expression and clinical significance of CC-chemokine receptor 7 in a large collection of prostate cancer (PCa) samples and explored its function on the proliferation and migration of PCa cells. [Tumor Biol] Abstract Anti-Proliferative Effect and Induction of Apoptosis in Androgen-Independent Human Prostate Cancer Cells by 1,5-Bis(2-Hydroxyphenyl)-1,4-Pentadiene-3-One Researchers determined the anti-cancer properties of four selected curcumin analogues, on the cytotoxicity, proliferative and apoptotic effects on androgen-independent human prostate cancer cells. [Molecules] Abstract | Download Full Article CLINICAL RESEARCH Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy plus Radiotherapy versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer Scientists previously reported that radiotherapy added to androgen-deprivation therapy improves survival in men with locally advanced prostate cancer. Here, they report the prespecified final analysis of this randomized trial. [J Clin Oncol] Full Article Neoadjuvant Luteinizing-Hormone-Releasing Hormone Agonist plus Low-Dose Estramustine Phosphate Improves Prostate-Specific Antigen-Free Survival in High-Risk Prostate Cancer Patients: A Propensity Score-Matched Analysis Researchers used a retrospective design via propensity score matching to elucidate the clinical benefit of neoadjuvant luteinizing-hormone-releasing hormone agonist plus low dose estramustine phosphate for high-risk prostate cancer. [Int J Clin Oncol] Abstract |